CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $40,883
- in 1 filing
Net +$959,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-01 | Touchon Pascal President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +242,000 | 242,000 | ||
| 2020-02-18 | Yarema Kristin Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2020-02-06 | Newell Joe Chief Tech. Operations Officer | Sale | −4,117 | $14.21 | $59K | 53,881 |
| 2020-02-06 | Koppikar Utpal Chief Financial Officer | Sale | −1,781 | $14.21 | $25K | 72,282 |
| 2020-01-24 | Touchon Pascal President and CEO | Shares withheld for taxes | −9,900 | $13.62 | $135K | 130,174 |
| 2019-09-27 | Newell Joe Chief Tech. Operations Officer | Sale | −3,500 | $13.51 | $47K | 57,998 |
| 2019-06-27 | SEIDENBERG BETH C Director | Grant or award | +4,000 | 19,189 | ||
| 2019-06-27 | SEIDENBERG BETH C Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2019-06-27 | DOBMEIER ERIC Director | Purchase | +2,000 | $19.50 | $39K | 16,000 |
| 2019-06-27 | DOBMEIER ERIC Director | Grant or award | +4,000 | 20,000 | ||
| 2019-06-27 | DOBMEIER ERIC Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2019-06-27 | Gallagher Carol Giltner Director | Grant or award | +4,000 | 92,818 | ||
| 2019-06-27 | Gallagher Carol Giltner Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2019-06-27 | Fust Matthew K Director | Grant or award | +4,000 | 25,854 | ||
| 2019-06-27 | Fust Matthew K Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2019-06-27 | HEIDEN WILLIAM K Director | Grant or award | +4,000 | 12,500 | ||
| 2019-06-27 | HEIDEN WILLIAM K Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2019-06-27 | Baynes Roy D. Director | Grant or award | +4,000 | 4,000 | ||
| 2019-06-27 | Baynes Roy D. Director | Grant or award · Non-Qualified Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2019-06-24 | Touchon Pascal President and CEO | Grant or award | +140,074 | 140,074 |
Page 19 of 29 · 569 trades